$Outcomes of patients with IDH1-mutant relapsed or refractory acute myeloid leukemia receiving ivosidenib who proceeded to hematopoietic stem cell transplant$

Outcomes of patients with IDH1-mutant relapsed or refractory acute myeloid leukemia receiving ivosidenib who proceeded to hematopoietic stem cell transplant

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia 2021-11, Vol.35 (11), p.3278-3281
Hauptverfasser:	DiNardo, Courtney D., Stein, Eytan M., Pigneux, Arnaud, Altman, Jessica K., Collins, Robert, Erba, Harry P., Watts, Justin M., Uy, Geoffrey L., Winkler, Thomas, Wang, Hongfang, Choe, Sung, Liu, Hua, Wu, Bin, Kapsalis, Stephanie M., Roboz, Gail J., de Botton, Stéphane
Format:	Artikel
Sprache:	eng
Schlagworte:	631/67/1059/602 631/67/1990/283 692/699/1541 692/699/67/1990/283/1897 692/700/565/1436/2185 Acute myeloid leukemia Adult Aged Antineoplastic Agents - therapeutic use Bone marrow Cancer Cancer Research Cancer therapies Chemotherapy Combined Modality Therapy Critical Care Medicine Dehydrogenases Drug dosages Drug resistance Drug Resistance, Neoplasm Enzymes Female Follow-Up Studies Glycine - analogs & derivatives Glycine - therapeutic use Hematology Hematopoietic Stem Cell Transplantation - mortality Hematopoietic stem cells Humans Intensive Internal Medicine Isocitrate Dehydrogenase - genetics Letter Leukemia Leukemia, Myeloid, Acute - genetics Leukemia, Myeloid, Acute - mortality Leukemia, Myeloid, Acute - pathology Leukemia, Myeloid, Acute - therapy Life Sciences & Biomedicine Male Medicine Medicine & Public Health Metabolism Metabolites Middle Aged Mutation Myeloid leukemia Neoplasm Recurrence, Local - genetics Neoplasm Recurrence, Local - mortality Neoplasm Recurrence, Local - pathology Neoplasm Recurrence, Local - therapy Oncology Patient outcomes Patients Prognosis Pyridines - therapeutic use Relapse Remission (Medicine) Science & Technology Stem cell transplantation Stem cells Survival Rate Transplantation
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:
ISSN:	0887-6924 1476-5551
DOI:	10.1038/s41375-021-01229-x